Blood

Published by: American Society of Hematology  

People

  1. Devlin
    Devlin
  2. Giralt
    Giralt
  3. Perales
    Perales
  4. Heller
    Heller
  5. Landau
    Landau
  6. Lesokhin
    Lesokhin
  7. Shah
    Shah
  8. O'Reilly
    O'Reilly
  9. Hassoun
    Hassoun
  10. Papadopoulos
    Papadopoulos

Groups

  1. Biostatistics Service (390)
  2. Epidemiology and Biostatistics (390)
  3. Department of Medicine (364)
  4. Hematologic Malignancies, Division of (351)
  5. Center for Hematologic Malignancies (345)
  6. Bone Marrow Transplant (191)
  7. Survivorship Research (177)
  8. GSK Faculty (174)
  9. Executive Committee, Center for Hematologic Malignancies (128)
  10. CTCR Scholars (117)
Search Within
  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (312)
  2. Journal Article (77)
  3. Research Letter (1)
Groups
  1. Biostatistics Service (390)
  2. Epidemiology and Biostatistics (390)
  3. Department of Medicine (364)
  4. Hematologic Malignancies, Division of (351)
  5. Center for Hematologic Malignancies (345)
  6. Bone Marrow Transplant (191)

More Groups

People
  1. Sean Devlin (178)
  2. Sergio Giralt (135)
  3. Miguel-Angel Perales (81)
  4. Glenn Heller (69)
  5. Marcel Van Den Brink (57)
  6. Heather Landau (56)

More People

Years
  1. 2023 (22)
  2. 2022 (30)
  3. 2021 (22)
  4. 2020 (23)
  5. 2019 (27)
  6. 2018 (28)

More Years

Publishers
  1. American Society of Hematology (390)

Results (390)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Difference in involved and uninvolved free light chain (dFLC) of less than 1mg/DL early post risk adapted melphalan and autologous stem cell transplantation (RA-ASCT) predicts renal response at 1 year in light chain (AL) amyloidosis
    Meeting Abstract

    Purvey, S.; Seier, K.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Shah, G. L.; Hassoun, H.; Giralt, S. A.; Landau, H. J.
    Blood (2019)

    Fulltext@MSK | Save
  • Comparing gradings of immune effector cells toxicities: Application of ASTCT consensus grading system and implications for clinical management
    Meeting Abstract

    Pennisi, M.; Jain, T.; Mead, E.; Santomasso, B.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Maloy, M. A.; Devlin, S. M.; Batlevi, C. L.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • EASIX and modified-EASIX are early predictors of severe cytokine release syndrome and neurotoxicity in patients treated with chimeric antigen receptor T cells
    Meeting Abstract

    Pennisi, M.; Sanchez-Escamilla, M.; Flynn, J.; Maloy, M. A.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Batlevi, C. L.; Brentjens, R. J.; Devlin, S. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Clinical factors associated with improved survival following allogeneic HSCT after CD19 CAR therapy in adult patients with relapsed B-ALL
    Meeting Abstract

    Park, J. H.; Flynn, J.; Gonen, M.; Bernal, Y.; Diamonte, C.; Halton, E.; Wang, X.; Riviere, I.; Sadelain, M.; Brentjens, R. J.
    Blood (2019)

    Fulltext@MSK | Save
  • Dynamic easix scores closely predict non-relapse mortality after allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Nawas, M. T.; Sanchez-Escamilla, M.; Devlin, S. M.; Maloy, M. A.; Giralt, S. A.; Perales, M. A.; Scordo, M.
    Blood (2019)

    Fulltext@MSK | Save
  • A phase Ib/II study of the histone methyltransferase inhibitor pinometostat in combination with azacitidine in patients with 11q23-rearranged acute myeloid leukemia
    Meeting Abstract

    Menghrajani, K.; Cai, S. F.; Devlin, S. M.; Armstrong, S. A.; Piekarz, R.; Rudek, M.; Tallman, M. S.; Stein, E. M.
    Blood (2019)

    Fulltext@MSK | Save
  • The geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in combination with multi-morbidity and functional impairment
    Meeting Abstract

    Lin, R. J.; Michaud, L.; Lobaugh, S. M.; Nakajima, R.; Elko, T. A.; Ruiz, J. D.; Sauter, C. S.; Dahi, P. B.; Maloy, M. A.; Perales, M. A.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Impact and safety of chimeric antigen receptor T cell therapy in vulnerable older patients with relapsed/refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Lin, R. J.; Lobaugh, S. M.; Pennisi, M.; Chan, J. T.; Batlevi, Y.; Ruiz, J. D.; Elko, T. A.; Maloy, M. A.; Batlevi, C. L.; Dahi, P. B.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Long-term sustained minimal residual disease (MRD) negativity in multiple myeloma patients treated with lenalidomide maintenance therapy: A clinical and correlative phase 2 study
    Meeting Abstract

    Landgren, O.; Mastey, D.; Lesokhin, A. M.; Smith, E. L.; Shah, U. A.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Salcedo, M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Hematological count recovery in patients undergoing treatment with chimeric antigen receptor T cells (CAR T)
    Meeting Abstract

    Jain, T.; Knezevic, A.; Pennisi, M.; Ruiz, J. D.; Devlin, S. M.; Maloy, M. A.; Halton, E.; Diamonte, C.; Scordo, M.; Sauter, C. S.; more...
    Blood (2019)

    Fulltext@MSK | Save

    • Blood – authorized name for:

    Name ISSN / ISBN Publisher
    Blood 0006-4971 American Society of Hematology
    Blood 00064971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 00064971 Unknown
    Blood 0006-4971 American Society of Hematology
    Blood 15280020 American Society of Hematology
    Blood 0006-4971 W.B. Saunders Co.
    Blood 1528-0020 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 15280020 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 00064971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology and American Society of Clinical Oncology
    Blood 0006-4971 American Society of Hematology
    Blood 15280020 Unknown
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 W.B. Saunders Co.
    Blood 1528-0020 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 00064971 2023
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology and American Society of Clinical Oncology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 1528-0020 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology